Search

everythinglearnresearchcommunity

for

Search:↓

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Optical imaging and light therapy show promise for diagnosing and treating liver injury caused by surgery.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Anti-cancer drugs are diverse and hard to classify due to their different forms and actions.

Plant compounds may offer a promising alternative for cancer treatment.

Promising cancer treatments were found, but the manufacturer closed.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Enhancing immune response can improve cancer treatment effectiveness.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Metformin may help treat neuroendocrine tumors.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Plant-based medicines can effectively prevent and treat cancer with fewer side effects.

Imuvert can prevent some chemotherapy-induced hair loss.